EP1934217A4 - Neue verbindungen ii - Google Patents
Neue verbindungen iiInfo
- Publication number
- EP1934217A4 EP1934217A4 EP06799715A EP06799715A EP1934217A4 EP 1934217 A4 EP1934217 A4 EP 1934217A4 EP 06799715 A EP06799715 A EP 06799715A EP 06799715 A EP06799715 A EP 06799715A EP 1934217 A4 EP1934217 A4 EP 1934217A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- new compounds
- compounds
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0502173 | 2005-10-03 | ||
PCT/SE2006/001115 WO2007040439A1 (en) | 2005-10-03 | 2006-10-02 | New compounds ii |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1934217A1 EP1934217A1 (de) | 2008-06-25 |
EP1934217A4 true EP1934217A4 (de) | 2010-08-04 |
Family
ID=37906402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06799715A Withdrawn EP1934217A4 (de) | 2005-10-03 | 2006-10-02 | Neue verbindungen ii |
Country Status (16)
Country | Link |
---|---|
US (1) | US20080255106A1 (de) |
EP (1) | EP1934217A4 (de) |
JP (1) | JP2009510162A (de) |
KR (1) | KR20080057334A (de) |
CN (1) | CN101321754A (de) |
AR (1) | AR057525A1 (de) |
AU (1) | AU2006297889A1 (de) |
BR (1) | BRPI0616663A2 (de) |
CA (1) | CA2624869A1 (de) |
IL (1) | IL189945A0 (de) |
NO (1) | NO20082054L (de) |
SA (1) | SA06270365B1 (de) |
TW (1) | TW200800984A (de) |
UY (1) | UY29823A1 (de) |
WO (1) | WO2007040439A1 (de) |
ZA (1) | ZA200802637B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY29825A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones |
CA2637392A1 (en) * | 2006-01-23 | 2007-07-26 | Crystalgenomics, Inc. | Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
AU2008233319A1 (en) * | 2007-03-30 | 2008-10-09 | Astrazeneca Ab | New imidazo[ 4,5-B]pyridine-7-carboxamides 704 |
CN102127070A (zh) * | 2010-01-15 | 2011-07-20 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
US9133186B2 (en) * | 2010-09-10 | 2015-09-15 | Shionogi & Co., Ltd. | Hetero ring-fused imidazole derivative having AMPK activating effect |
WO2016008966A1 (en) | 2014-07-17 | 2016-01-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for treating neuromuscular junction-related diseases |
WO2016207366A1 (en) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
GB201519573D0 (en) | 2015-11-05 | 2015-12-23 | King S College London | Combination |
CN107151235B (zh) * | 2016-03-04 | 2019-12-13 | 上海市计划生育科学研究所 | 噻二唑烷二酮基gsk3抑制剂在调节精子运动能力中的用途 |
US10774086B2 (en) * | 2016-11-28 | 2020-09-15 | Bristol-Myers Squibb Company | GSK-3 inhibitors |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003066629A2 (en) * | 2002-02-06 | 2003-08-14 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds useful as inhibitors of gsk-3 |
WO2004065370A1 (en) * | 2003-01-23 | 2004-08-05 | Crystalgenomics, Inc. | Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof |
WO2007083978A1 (en) * | 2006-01-23 | 2007-07-26 | Crystalgenomics, Inc. | Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3711238B2 (ja) * | 1997-08-05 | 2005-11-02 | ファイザー・プロダクツ・インク | 神経ペプチドY受容体アンタゴニストとしての4−アミノピロ−ル(3,2−d)ピリミジン |
US6187777B1 (en) * | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
ATE384722T1 (de) * | 2002-03-27 | 2008-02-15 | Nycomed Gmbh | Alkoxypyridinderivate |
SE0202462D0 (sv) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel use |
EA200600607A1 (ru) * | 2003-10-01 | 2006-10-27 | Алтана Фарма Аг | Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы |
ES2309567T3 (es) * | 2003-10-01 | 2008-12-16 | Nycomed Gmbh | Derivados de imidazopiridinas como inhibidores de no-sintasa inducible. |
UY29825A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones |
-
2006
- 2006-09-29 AR ARP060104309A patent/AR057525A1/es not_active Application Discontinuation
- 2006-09-29 UY UY29823A patent/UY29823A1/es not_active Application Discontinuation
- 2006-10-02 JP JP2008534485A patent/JP2009510162A/ja active Pending
- 2006-10-02 BR BRPI0616663-6A patent/BRPI0616663A2/pt not_active IP Right Cessation
- 2006-10-02 CN CNA2006800453255A patent/CN101321754A/zh active Pending
- 2006-10-02 EP EP06799715A patent/EP1934217A4/de not_active Withdrawn
- 2006-10-02 AU AU2006297889A patent/AU2006297889A1/en not_active Abandoned
- 2006-10-02 CA CA002624869A patent/CA2624869A1/en not_active Abandoned
- 2006-10-02 WO PCT/SE2006/001115 patent/WO2007040439A1/en active Application Filing
- 2006-10-02 US US12/088,897 patent/US20080255106A1/en not_active Abandoned
- 2006-10-02 KR KR1020087010754A patent/KR20080057334A/ko not_active Application Discontinuation
- 2006-10-03 TW TW095136782A patent/TW200800984A/zh unknown
- 2006-10-03 SA SA06270365A patent/SA06270365B1/ar unknown
-
2008
- 2008-03-04 IL IL189945A patent/IL189945A0/en unknown
- 2008-03-25 ZA ZA200802637A patent/ZA200802637B/xx unknown
- 2008-04-30 NO NO20082054A patent/NO20082054L/no not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003066629A2 (en) * | 2002-02-06 | 2003-08-14 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds useful as inhibitors of gsk-3 |
WO2004065370A1 (en) * | 2003-01-23 | 2004-08-05 | Crystalgenomics, Inc. | Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof |
WO2007083978A1 (en) * | 2006-01-23 | 2007-07-26 | Crystalgenomics, Inc. | Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
Non-Patent Citations (1)
Title |
---|
See also references of WO2007040439A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2009510162A (ja) | 2009-03-12 |
ZA200802637B (en) | 2008-12-31 |
NO20082054L (no) | 2008-06-02 |
AU2006297889A1 (en) | 2007-04-12 |
CA2624869A1 (en) | 2007-04-12 |
WO2007040439A1 (en) | 2007-04-12 |
IL189945A0 (en) | 2008-08-07 |
EP1934217A1 (de) | 2008-06-25 |
KR20080057334A (ko) | 2008-06-24 |
CN101321754A (zh) | 2008-12-10 |
SA06270365B1 (ar) | 2009-12-22 |
UY29823A1 (es) | 2007-05-31 |
TW200800984A (en) | 2008-01-01 |
AR057525A1 (es) | 2007-12-05 |
US20080255106A1 (en) | 2008-10-16 |
BRPI0616663A2 (pt) | 2011-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0503962D0 (en) | Compounds | |
GB0502418D0 (en) | Compounds | |
GB0502316D0 (en) | Compounds | |
EP1961741A4 (de) | m-CARBAZOLYLPHENYLVERBINDUNGEN | |
HU0500920D0 (en) | New compounds | |
HK1121755A1 (en) | New compounds iii | |
GB0502299D0 (en) | Compounds | |
GB0502310D0 (en) | Compounds | |
HU0500921D0 (en) | New compounds | |
EP1934217A4 (de) | Neue verbindungen ii | |
AP2007004220A0 (en) | Motilide compounds | |
GB0505084D0 (en) | Compounds | |
GB0503961D0 (en) | Compounds | |
EP1907385A4 (de) | Verbindungen | |
GB0505086D0 (en) | Compounds | |
HU0501168D0 (en) | New compounds | |
HU0501170D0 (en) | New compounds | |
HU0500886D0 (en) | New compounds | |
HU0500877D0 (en) | New compounds | |
HU0500879D0 (en) | New compounds | |
GB0501985D0 (en) | Compounds | |
EP1867650A4 (de) | Hydroxymethylborverbindungen | |
GB0505085D0 (en) | Compounds | |
GB0501984D0 (en) | Compounds | |
HU0501166D0 (en) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080506 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: HR |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ASTRAZENECA AB |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1120262 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100705 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110202 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1120262 Country of ref document: HK |